|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Quanterix Garners New Funding Round
|
VentureDeal |
01/05/12 |
Boston
|
|
HubSpot Buys OneForty, Cambridge Diagnostics Startups Nab Funding, Hopper Closes $8M, & More Boston-Area Deals News
|
Erin Kutz |
08/24/11 |
Boston
|
|
Quanterix Finds $6M
|
Erin Kutz |
08/23/11 |
Boston
|
|
Quanterix Receives $5,999,998 New Round
|
VentureDeal |
08/19/11 |
Boston
|
|
Quanterix Partners With Novartis, Athenahealth and Microsoft Sync Up, Vertex Nails Clinical Trial, & More Boston-Area Life Sciences News
|
Erin Kutz |
02/25/11 |
Boston
|
|
Quanterix, Novartis Test Out Super-Sensitive Diagnostic Tool for Neuro Disorder
|
Luke Timmerman |
02/22/11 |
Boston
|
|
Quanterix Adds Former Millipore CEO as Chair
|
Luke Timmerman |
12/01/10 |
Boston
|
|
Akrivis Sets Out to Improve Diagnostics and Therapies with Northeastern U. Tech
|
Ryan McBride |
11/23/10 |
Boston
|
|
Ouch for Arch: VC Bob Nelsen Says Ikaria Will March On After Withdrawing Big IPO
|
Luke Timmerman |
11/12/10 |
Seattle
|
|
Big Fish Help Out the Smaller Fish in the Life Sciences Pond
|
Sylvia Pagán Westphal |
11/09/10 |
National
|
|
Shots from the Front Row of Boston’s War on Cancer Event
|
Ryan McBride |
10/22/10 |
Boston
|
|
Alkermes Drug Approved for Opioid Addiction, Genzyme Faces Shareholder Lawsuits, NinePoint Gets $33M, & More Boston-Area Life Sciences News
|
Erin Kutz |
10/15/10 |
Boston
|
|
Mike Huckman, Former CNBC Reporting Ace, Joins Stellar Lineup at Boston’s War on Cancer
|
Luke Timmerman |
10/14/10 |
Boston
|
|
Where Will the Next Gleevec Come From? Xconomy Forum Looks At the Edge of Cancer R&D
|
Luke Timmerman |
10/05/10 |
Boston
|
|
What Is Boston Doing for the War on Cancer? Find Out at Xconomy Forum on October 20
|
Luke Timmerman |
08/25/10 |
Boston
|
|
FDA Approves Genzyme Pompe Drug, Vertex Hepatitis C Drug Trial Succeeds, Thermo Fisher Acquires Fermentas, & More Boston-Area Life Sciences News
|
Erin Kutz |
05/28/10 |
Boston
|
|
Quanterix Uses Fiber Optics to Find Cancer Protein, Nears New Funding Round
|
Ryan McBride |
05/27/10 |
Boston
|
|
IkaSystems Raises $120M, New CEOs of Qteros, Bind, and Quanterix Dish the Dirt, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
01/20/10 |
Boston
|
|
Quanterix CEO Sets Sight on Early Detection of Cancer, Neurological Diseases in the Blood
|
Luke Timmerman |
01/19/10 |
Boston
|
|
New VC in Boston: Arch Venture Partners Opens Small Office With Eye Toward Basic Science, Multidisciplinary Collaborations
|
Robert Buderi |
09/21/09 |
Boston
|
|
Federal Judge Rules in Biogen Idec’s Favor, Sepracor Agrees to $2.8B Buyout, FDA Panel Endorses Gloucester Pharma Drug, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
09/11/09 |
Boston
|
|
Quanterix Taps New CEO
|
Ryan McBride |
09/02/09 |
Boston
|
|
How to Build a Billion-Dollar Company (And Keep An Academic Day Job), According to David Walt
|
Luke Timmerman |
08/31/09 |
National
|
|
Seventh Sense Biosystems Developing Tech Akin to Check-Engine Light for the Body
|
Ryan McBride |
06/05/09 |
Boston
|
|
New England’s Top Third-Quarter Venture Deals—the List
|
Robert Buderi |
10/20/08 |
Boston
|
|
New Biotech Biz Models (and the Tested Bob Langer-Terry McGuire Approach) Emerge at Xconomy Forum
|
Ryan McBride |
09/25/08 |
Boston
|
|
How to Build a Life Sciences Company: Xconomy Forum Tomorrow
|
Robert Buderi |
09/22/08 |
Boston
|
|
Pharmas Flock to Sermo, Biogen Idec Takes Another Tack with MS, $400M More for the Broad Institute, & More Life Sciences News
|
Rebecca Zacks |
09/04/08 |
Boston
|
|
Investors Radio in $32M for Vanu, JumpTap’s Bank Balance Hops up by $26M, Quanterix Pinpoints $15M, & More Deals News
|
Rebecca Zacks |
09/02/08 |
Boston
|
|
Quanterix Developing Instrument to Detect Cancer at its Earliest, Most Curable Stages
|
Luke Timmerman |
08/29/08 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.